Dmitry Gerashchenko, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase Type I | 5 | 2019 | 171 | 1.460 |
Why?
|
| Sleep | 22 | 2023 | 4813 | 1.210 |
Why?
|
| Cerebral Cortex | 10 | 2024 | 5767 | 0.800 |
Why?
|
| Neuropeptides | 9 | 2011 | 951 | 0.750 |
Why?
|
| Neurons | 16 | 2022 | 9525 | 0.700 |
Why?
|
| Sleep Deprivation | 7 | 2018 | 845 | 0.670 |
Why?
|
| Delta Rhythm | 1 | 2019 | 81 | 0.630 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 2010 | 108 | 0.580 |
Why?
|
| Somatostatin | 1 | 2019 | 459 | 0.570 |
Why?
|
| Substance P | 1 | 2017 | 331 | 0.520 |
Why?
|
| Wakefulness | 10 | 2022 | 1282 | 0.500 |
Why?
|
| Cholera Toxin | 1 | 2017 | 563 | 0.470 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2011 | 2880 | 0.440 |
Why?
|
| Interneurons | 4 | 2022 | 593 | 0.420 |
Why?
|
| Telemetry | 1 | 2013 | 201 | 0.380 |
Why?
|
| Opioid Peptides | 1 | 2010 | 37 | 0.360 |
Why?
|
| Sleep Stages | 2 | 2024 | 698 | 0.360 |
Why?
|
| Receptors, Opioid | 1 | 2010 | 144 | 0.350 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 605 | 0.350 |
Why?
|
| Hypothalamus | 3 | 2004 | 993 | 0.340 |
Why?
|
| Memory | 1 | 2019 | 2190 | 0.330 |
Why?
|
| Pain Perception | 1 | 2010 | 198 | 0.320 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1445 | 0.310 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 1028 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2018 | 576 | 0.290 |
Why?
|
| Polysomnography | 3 | 2017 | 1859 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2014 | 8102 | 0.270 |
Why?
|
| Mice, Transgenic | 6 | 2024 | 9550 | 0.270 |
Why?
|
| Analgesia | 1 | 2010 | 461 | 0.260 |
Why?
|
| Movement | 1 | 2013 | 1462 | 0.260 |
Why?
|
| Narcolepsy | 2 | 2011 | 195 | 0.260 |
Why?
|
| Electroencephalography | 10 | 2022 | 6273 | 0.250 |
Why?
|
| Immunotoxins | 3 | 2017 | 177 | 0.240 |
Why?
|
| Animals | 36 | 2024 | 168764 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2024 | 707 | 0.220 |
Why?
|
| Homeostasis | 3 | 2010 | 3336 | 0.220 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1402 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4348 | 0.210 |
Why?
|
| Histamine | 1 | 2004 | 497 | 0.210 |
Why?
|
| Phytochrome | 1 | 2022 | 8 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11888 | 0.200 |
Why?
|
| Mice | 19 | 2024 | 81819 | 0.200 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 8730 | 0.190 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 1998 | 105 | 0.180 |
Why?
|
| Brain | 3 | 2017 | 27171 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2024 | 2143 | 0.160 |
Why?
|
| Rats | 14 | 2013 | 23707 | 0.160 |
Why?
|
| Electromyography | 5 | 2018 | 1399 | 0.160 |
Why?
|
| Plant Proteins | 3 | 2007 | 374 | 0.150 |
Why?
|
| Infusions, Intraventricular | 1 | 2017 | 31 | 0.150 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 3 | 2007 | 28 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 1998 | 152 | 0.140 |
Why?
|
| Arousal | 3 | 2009 | 1171 | 0.140 |
Why?
|
| Ciliary Body | 1 | 1998 | 168 | 0.140 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2017 | 133 | 0.140 |
Why?
|
| Iris | 1 | 1998 | 232 | 0.130 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2216 | 0.130 |
Why?
|
| Astrocytes | 1 | 2024 | 1345 | 0.130 |
Why?
|
| Adenosine | 3 | 2008 | 806 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4913 | 0.130 |
Why?
|
| Photic Stimulation | 1 | 2022 | 1993 | 0.130 |
Why?
|
| Vitreous Body | 1 | 1998 | 400 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2022 | 885 | 0.120 |
Why?
|
| Periodicity | 2 | 2007 | 345 | 0.120 |
Why?
|
| Circadian Rhythm | 5 | 2008 | 2592 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18293 | 0.110 |
Why?
|
| Cell Count | 3 | 2013 | 1823 | 0.100 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1048 | 0.100 |
Why?
|
| Subthalamus | 1 | 2011 | 4 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2017 | 543 | 0.090 |
Why?
|
| Cataplexy | 1 | 2011 | 61 | 0.090 |
Why?
|
| Male | 19 | 2024 | 363698 | 0.090 |
Why?
|
| Microinjections | 1 | 2010 | 320 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 22332 | 0.080 |
Why?
|
| Brain Waves | 1 | 2013 | 417 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2017 | 1191 | 0.080 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2009 | 139 | 0.080 |
Why?
|
| Restraint, Physical | 1 | 2010 | 186 | 0.080 |
Why?
|
| Hippocampus | 2 | 2022 | 3775 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2024 | 1116 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2008 | 256 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14448 | 0.070 |
Why?
|
| Prostaglandin D2 | 1 | 2008 | 109 | 0.070 |
Why?
|
| Alpha Rhythm | 1 | 2008 | 108 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 911 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 2548 | 0.070 |
Why?
|
| Toxins, Biological | 2 | 2004 | 60 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 2 | 1998 | 209 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2008 | 952 | 0.070 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2006 | 106 | 0.060 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 11022 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2008 | 1263 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12768 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2024 | 23601 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2844 | 0.060 |
Why?
|
| Hypothalamus, Posterior | 1 | 2004 | 12 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6203 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2411 | 0.060 |
Why?
|
| Inflammation | 1 | 2004 | 10850 | 0.060 |
Why?
|
| Gene Expression | 1 | 2017 | 7584 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2006 | 305 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 1140 | 0.060 |
Why?
|
| Muscle Tonus | 1 | 2004 | 82 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2024 | 2674 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 187 | 0.050 |
Why?
|
| Sleep, REM | 2 | 2004 | 588 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 227 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 616 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 1 | 2003 | 106 | 0.050 |
Why?
|
| Action Potentials | 2 | 2009 | 1838 | 0.050 |
Why?
|
| Infrared Rays | 1 | 2024 | 246 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2004 | 251 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 153 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3785 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 38 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2004 | 4392 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1865 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2024 | 485 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2010 | 3561 | 0.040 |
Why?
|
| Preoptic Area | 1 | 2001 | 132 | 0.040 |
Why?
|
| Lipocalins | 2 | 1998 | 162 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 663 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 748 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 772 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 425 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2024 | 1470 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 1886 | 0.030 |
Why?
|
| Isomerases | 1 | 1996 | 54 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1125 | 0.030 |
Why?
|
| Salivary Proteins and Peptides | 1 | 1996 | 48 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 1242 | 0.030 |
Why?
|
| Light | 1 | 2022 | 1365 | 0.030 |
Why?
|
| Period Circadian Proteins | 2 | 2008 | 97 | 0.030 |
Why?
|
| Thalamus | 1 | 2022 | 1048 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1996 | 234 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 1998 | 387 | 0.030 |
Why?
|
| Calcium | 2 | 2023 | 5767 | 0.030 |
Why?
|
| Phenethylamines | 2 | 2008 | 95 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1372 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 5747 | 0.030 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2008 | 127 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2004 | 3085 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5783 | 0.030 |
Why?
|
| Body Temperature | 2 | 2009 | 779 | 0.030 |
Why?
|
| Blotting, Western | 2 | 1998 | 5020 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2024 | 8278 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3634 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3896 | 0.020 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2009 | 17 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6601 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6220 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 1727 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2008 | 41 | 0.020 |
Why?
|
| Cryptochromes | 1 | 2008 | 49 | 0.020 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2008 | 31 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2008 | 88 | 0.020 |
Why?
|
| Motor Activity | 2 | 2009 | 2704 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 918 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 1216 | 0.020 |
Why?
|
| Phenotype | 1 | 2004 | 16721 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 1770 | 0.020 |
Why?
|
| Aging | 1 | 2004 | 8731 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 3430 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2004 | 68 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 127 | 0.010 |
Why?
|
| Species Specificity | 1 | 2008 | 2406 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2008 | 1884 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 860 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 13024 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 822 | 0.010 |
Why?
|
| Pons | 1 | 2004 | 238 | 0.010 |
Why?
|
| Humans | 5 | 2024 | 765968 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1744 | 0.010 |
Why?
|
| Stroke | 1 | 2024 | 9747 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2004 | 900 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2001 | 77 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 220 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3797 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 830 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2008 | 2850 | 0.010 |
Why?
|
| Lipocalin 1 | 1 | 1996 | 2 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4562 | 0.010 |
Why?
|
| Transcription Factors | 2 | 2008 | 12131 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1546 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 6897 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2266 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10729 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2033 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9249 | 0.000 |
Why?
|
| Female | 3 | 2009 | 396112 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2657 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40065 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 30198 | 0.000 |
Why?
|